Improving Drug Delivery

Courtesy of Langer Research Lab, MITRobert Langer is a professor of chemical and biomedical engi neering at the Massachusetts Institute of Technology. He has written more than 800 articles, has more than 500 issued or pending patents worldwide, and has licensed his patents to 120 companies. In 2002 Langer was awarded the $500,000 Charles Draper prize, considered to be the Nobel Prize of engineering, and in 1999, Forbes Magazine named him one of the 25 most important people in biotechnology.Advan

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Courtesy of Langer Research Lab, MIT

Robert Langer is a professor of chemical and biomedical engi neering at the Massachusetts Institute of Technology. He has written more than 800 articles, has more than 500 issued or pending patents worldwide, and has licensed his patents to 120 companies. In 2002 Langer was awarded the $500,000 Charles Draper prize, considered to be the Nobel Prize of engineering, and in 1999, Forbes Magazine named him one of the 25 most important people in biotechnology.

Advanced drug delivery systems barely existed 25 years ago, but there has been such rapid research progress that more than 30 million people in the United States now use novel delivery systems each year. In general, advanced systems release a drug at a controlled rate for a prolonged period of time (as long as five years from a single implant), deliver the drug at specific sites in the human ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Robert Langer

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours